The Overview: November 2020
We’re full on into fall, and giving thanks for all that we’ve accomplished together, in a year that’s been more than a little challenging. RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS EVENTS WAYS TO GIVE
News
Give the gift that keeps on giving … in more ways than one
We’ve got the perfect gift for everyone on your holiday list, and you never have to step foot in a store. With a suggested donation of $25 or more, you can give someone a series of wellness videos led by fitness instructors from around the U.S., including meditation, yoga, sweat sessions, conscious breathing, and more. … Continued
Now Accepting Applications for 2021 Advocate Leader Program
Be a voice for the ovarian cancer community. Please note: The deadline for application was December 7, 2020. Sign up for email alerts to stay updated on opportunities to take action! Apply today to join survivors, caregivers and activists from across the country using their voices to affect change for those touched by ovarian cancer. As … Continued
Watch Expert Presentations from OCRA’s 2020 Virtual National Conference
Want to learn what’s new in ovarian cancer research and care for 2020? Start here. This fall, we hosted our virtual Uniting for Hope Ovarian Cancer National Conference, where experts in the field presented on a wide range of topics– demystifying genetic testing and precision medicine, providing resources for financial support, explaining clinical trials, and … Continued
OCRA’s Statement on SCOTUS and the Affordable Care Act (ACA)
The Supreme Court is poised to consider California v. Texas, which will decide the fate of the Affordable Care Act (ACA) — their decision could threaten health coverage for millions of people with pre-existing conditions, including ovarian cancer. OCRA is vigilantly monitoring this upcoming decision, and preparing strategies for addressing any outcomes that may threaten … Continued
Focusing on the Next Line of Defense Against Ovarian Cancer | Meet a Scientist
There is an 80% recurrence rate when it comes to ovarian cancer, so the question of ‘what next?’ takes on a huge importance. This is the question that Sarah Gitto, PhD, and her team in the Daniel J. Powell Lab at the University of Pennsylvania’s Ovarian Cancer Research Center, have set out to answer. They … Continued
OCRA Hosts Listening Session With FDA About COVID-19
OCRA Hosts Listening Session With FDA About COVID-19
In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation. Watch the full FDA listening session in the video below.
The Overview: October 2020
It’s been an incredibly busy end of summer/beginning of fall here at OCRA with a double header of Ovarian Cancer Awareness Month and our Uniting for Hope Ovarian Cancer National Conference. We’ve learned so much and strengthened our community. Here are just some of the ways: RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS OCRA HEROES EVENTS WAYS TO … Continued
A Look Back at Ovarian Cancer Awareness Month
What a whirlwind! You heard a lot from us this September, and we want to take just a moment to tell you how grateful we are for your support throughout Ovarian Cancer Awareness Month. With your help, we surpassed our fundraising goal, raising more than $235,000—an incredible achievement that will have a tangible effect in … Continued
Celebrities Come Out in Support of OCRA
Some well-known people with deeply personal connections to ovarian cancer have echoed what we’ve been saying all September…this disease is a beast. And it doesn’t get talked about enough. Research for better treatments and a cure doesn’t get the funding it deserves. What we all deserve. Listen to what they have to say, and what draws them … Continued
Everything You Need to Know About Johanna’s Law and Reauthorization
An important victory for the ovarian cancer community came in 2006 when Congress passed Johanna’s Law. What is Johanna’s Law? Also known as The Gynecologic Cancer Education and Awareness Act, the legislation supports a variety of programs, research projects and activities at Centers for Disease Control and Prevention (CDC) aimed at educating healthcare providers and … Continued
OCRA-Funded Research Shines Light on Genetic Factors that Contribute to Diagnosis
In order to understand the complexities of how gene mutations affect an ovarian cancer diagnosis, OCRA-funded researcher Alexander Nikitin, MD, PhD and colleagues looked to see which ones drive, or possibly delay, the onset of the disease. “We found there were various genes that would help the process along, but interestingly, there were other genes … Continued